Kyung Ju Kim

KRAS Mutation is Associated with Worse Prognosis in Stage III or High-risk Stage II Colon Cancer Patients Treated with Adjuvant FOLFOX

Dae-Won Lee, Kyung Ju Kim, Sae‐Won Han et al. · Annals of Surgical Oncology · 2014 · 82 citations

Medicine, Molecular Genetics, Oncology +15

p53 expression status is associated with cancer-specific survival in stage III and high-risk stage II colorectal cancer patients treated with oxaliplatin-based adjuvant chemotherapy

Hyeon Jeong Oh, Jeong Mo Bae, Xianyu Wen et al. · British Journal of Cancer · 2019 · 50 citations · Full text

Medicine, Oncology, Pathology +17

Distribution of intestinal stem cell markers in colorectal precancerous lesions

Bo Gun Jang, Hye Sung Kim, Kyung Ju Kim et al. · Histopathology · 2015 · 36 citations

Medicine, Molecular Biology, Oncology +17

Immunohistochemical Classification of Primary and Secondary Glioblastomas

Kyu Sang Lee, Gheeyoung Choe, Kyung Han Nam et al. · The Korean Journal of Pathology · 2013 · 29 citations · Full text

Medicine, Oncology, Pathology +17

Nuclear maspin expression correlates with the CpG island methylator phenotype and tumor aggressiveness in colorectal cancer.

Jung Ho Kim, Nam-Yun Cho, Jeong Mo Bae et al. · PubMed · 2015 · 18 citations

Medicine, Molecular Biology, Oncology +17